ETrade Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
$869K Buy
3,064
+439
+17% +$125K 0.02% 411
2020
Q2
$702K Sell
2,625
-356
-12% -$95.2K 0.01% 463
2020
Q1
$943K Sell
2,981
-4,049
-58% -$1.28M 0.02% 304
2019
Q4
$2.09M Buy
7,030
+25
+0.4% +$7.42K 0.05% 206
2019
Q3
$1.63M Buy
7,005
+924
+15% +$215K 0.04% 241
2019
Q2
$1.42M Buy
6,081
+746
+14% +$174K 0.04% 273
2019
Q1
$1.26M Sell
5,335
-2,113
-28% -$499K 0.04% 278
2018
Q4
$2.24M Sell
7,448
-185
-2% -$55.7K 0.07% 155
2018
Q3
$2.7M Sell
7,633
-846
-10% -$299K 0.08% 149
2018
Q2
$2.46M Buy
8,479
+843
+11% +$245K 0.08% 148
2018
Q1
$2.09M Sell
7,636
-691
-8% -$189K 0.07% 172
2017
Q4
$2.65M Buy
8,327
+314
+4% +$100K 0.09% 134
2017
Q3
$2.51M Buy
8,013
+546
+7% +$171K 0.09% 132
2017
Q2
$2.03M Buy
7,467
+66
+0.9% +$17.9K 0.08% 154
2017
Q1
$2.02M Buy
7,401
+1,061
+17% +$290K 0.08% 150
2016
Q4
$1.8M Buy
6,340
+1,715
+37% +$486K 0.08% 148
2016
Q3
$1.45M Buy
4,625
+1,789
+63% +$560K 0.07% 169
2016
Q2
$686K Buy
2,836
+1,020
+56% +$247K 0.04% 292
2016
Q1
$473K Buy
1,816
+856
+89% +$223K 0.03% 335
2015
Q4
$294K Buy
960
+217
+29% +$66.5K 0.02% 383
2015
Q3
$217K Buy
743
+205
+38% +$59.9K 0.01% 401
2015
Q2
$217K Buy
538
+8
+2% +$3.23K 0.01% 392
2015
Q1
$224K Buy
+530
New +$224K 0.01% 372
2014
Q3
Sell
-650
Closed -$205K 436
2014
Q2
$205K Buy
650
+454
+232% +$143K 0.01% 411
2014
Q1
$60K Sell
196
-1
-0.5% -$306 ﹤0.01% 545
2013
Q4
$55K Sell
197
-12
-6% -$3.35K ﹤0.01% 465
2013
Q3
$50K Buy
209
+18
+9% +$4.31K ﹤0.01% 428
2013
Q2
$41K Buy
+191
New +$41K ﹤0.01% 401